{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:55:36Z","timestamp":1773150936398,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016056"],"award-info":[{"award-number":["CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1038\/s41409-019-0591-4","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T18:10:39Z","timestamp":1561140639000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant"],"prefix":"10.1038","volume":"55","author":[{"given":"Megan M.","family":"Herr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallawi","family":"Torka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul K.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Joseph D.","family":"Tario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Repasky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia R.","family":"Balderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Hernandez-Ilizaliturri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-8855","authenticated-orcid":false,"given":"Theresa","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"591_CR1","unstructured":"D\u2019Souza A, Fretham C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR Summary Slides. 2017. https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.aspx."},{"key":"591_CR2","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.bbmt.2008.09.008","volume":"14","author":"HM Lazarus","year":"2008","unstructured":"Lazarus HM, Carreras J, Boudreau C, Loberiza FR Jr., Armitage JO, Bolwell BJ, et al. Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2008;14:1323\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bbmt.2008.05.002","volume":"14","author":"TM Wildes","year":"2008","unstructured":"Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF, et al. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant. 2008;14:840\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/10428190310001597900","volume":"45","author":"PL Zinzani","year":"2004","unstructured":"Zinzani PL, Tani M, Gabriele A, Gherlinzoni F, De Vivo A, Ricci P, et al. High-dose therapy with autologous transplantation for aggressive non-Hodgkin\u2019s lymphoma: the Bologna experience. Leuk Lymphoma. 2004;45:321\u20136.","journal-title":"Leuk Lymphoma"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbmt.2006.12.452","volume":"13","author":"RE Lerner","year":"2007","unstructured":"Lerner RE, Thomas W, Defor TE, Weisdorf DJ, Burns LJ. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin\u2019s lymphoma in second complete or partial remission. Biol Blood Marrow Transplant. 2007;13:486\u201392.","journal-title":"Biol Blood Marrow Transplant"},{"key":"591_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","volume":"21","author":"YB Chen","year":"2015","unstructured":"Chen YB, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, et al. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015;21:1046\u201353.","journal-title":"Biol Blood Marrow Transplant"},{"key":"591_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/sj.bmt.1705183","volume":"36","author":"R Dean","year":"2005","unstructured":"Dean R, Masci P, Pohlman B, Andresen S, Serafino S, Sobecks R, et al. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Bone Marrow Transplant. 2005;36:1049\u201352.","journal-title":"Bone Marrow Transplant"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.bbmt.2014.07.012","volume":"20","author":"LF Porrata","year":"2014","unstructured":"Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, et al. Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma. Biol Blood Marrow Transplant. 2014;20:1804\u201312.","journal-title":"Biol Blood Marrow Transplant"},{"key":"591_CR9","first-page":"832","volume":"85","author":"H Steingrimsdottir","year":"2000","unstructured":"Steingrimsdottir H, Gruber A, Bjorkholm M, Svensson A, Hansson M. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Haematologica . 2000;85:832\u20138.","journal-title":"Haematologica"},{"key":"591_CR10","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1111\/trf.13170","volume":"55","author":"J Valtola","year":"2015","unstructured":"Valtola J, Varmavuo V, Ropponen A, Nihtinen A, Partanen A, Vasala K, et al. Blood graft cellular composition and posttransplant recovery in non-Hodgkin\u2019s lymphoma patients mobilized with or without plerixafor: a prospective comparison. Transfusion. 2015;55:2358\u201368.","journal-title":"Transfusion"},{"key":"591_CR11","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/j.1537-2995.2012.03848.x","volume":"53","author":"V Varmavuo","year":"2013","unstructured":"Varmavuo V, Mantymaa P, Silvennoinen R, Nousiainen T, Kuittinen T, Jantunen E. CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients. Transfusion. 2013;53:1024\u201332.","journal-title":"Transfusion"},{"key":"591_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","volume":"18","author":"S Siena","year":"2000","unstructured":"Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol. 2000;18:1360\u201377.","journal-title":"J Clin Oncol"},{"key":"591_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","volume":"17","author":"PJ Stiff","year":"2011","unstructured":"Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, et al. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. Biol Blood Marrow Transplant. 2011;17:1146\u201353.","journal-title":"Biol Blood Marrow Transplant"},{"key":"591_CR14","doi-asserted-by":"crossref","unstructured":"Benekli M, Smiley SL, Younis T, Czuczman MS, Hernandez-Ilizaliturri F, Bambach B, et al. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma. Bone Marrow Transplant. 2008;41:613\u201319.","DOI":"10.1038\/sj.bmt.1705951"},{"key":"591_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/bloodadvances.2017005447","volume":"1","author":"CM Ho","year":"2017","unstructured":"Ho CM, McCarthy PL, Wallace PK, Zhang Y, Fora A, Mellors P, et al. Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT. Blood Adv. 2017;1:1056\u201366.","journal-title":"Blood Adv"},{"key":"591_CR16","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1200\/JCO.2014.60.1203","volume":"33","author":"R Reshef","year":"2015","unstructured":"Reshef R, Huffman AP, Gao A, Luskin MR, Frey NV, Gill SI, et al. High graft CD8 cell dose predicts improved survival and enables better donor selection in allogeneic stem-cell transplantation with reduced-intensity conditioning. J Clin Oncol. 2015;33:2392\u20138.","journal-title":"J Clin Oncol"},{"key":"591_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20131271","volume":"211","author":"ER Mehlhop-Williams","year":"2014","unstructured":"Mehlhop-Williams ER, Bevan MJ. Memory CD8+T cells exhibit increased antigen threshold requirements for recall proliferation. J Exp Med. 2014;211:345\u201356.","journal-title":"J Exp Med"},{"key":"591_CR18","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 2005;102:18538\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"591_CR19","doi-asserted-by":"publisher","first-page":"e80063","DOI":"10.1371\/journal.pone.0080063","volume":"8","author":"CC Preston","year":"2013","unstructured":"Preston CC, Maurer MJ, Oberg AL, Visscher DW, Kalli KR, Hartmann LC, et al. The ratios of CD8+ T cells to CD4+ CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer. PLoS ONE. 2013;8:e80063.","journal-title":"PLoS One"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492\u20139.","journal-title":"Nat Immunol"},{"key":"591_CR21","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","volume":"188","author":"AJ Zajac","year":"1998","unstructured":"Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJD, Suresh M, Altman JD, et al. Viral immune evasion due to persistence of activated T Cells without effector function. J Exp Med. 1998;188:2205\u201313.","journal-title":"J Exp Med"},{"key":"591_CR22","doi-asserted-by":"crossref","unstructured":"Reiser J, Banerjee A. Effector, memory, and dysfunctional CD8+ T cell fates in the antitumor immune response. J Immunol Res. 2016;2016:1\u201314.","DOI":"10.1155\/2016\/8941260"},{"key":"591_CR23","doi-asserted-by":"crossref","unstructured":"Kenderian SS, Porter DL, Gill S. Chimeric antigen receptor T cells and hematopoietic cell transplantation: How not to put the CART before the horse. Biol Blood Marrow Transplant. 2017;23:235\u201346.","DOI":"10.1016\/j.bbmt.2016.09.002"}],"updated-by":[{"DOI":"10.1038\/s41409-019-0647-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0591-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:59Z","timestamp":1684617299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0591-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0591-4","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41409-019-0647-5","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41409-019-0647-5","URL":"https:\/\/doi.org\/10.1038\/s41409-019-0647-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}